Home LiteratureArticle Details
PMID: 2680973 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Activation of C3 and binding to Aspergillus fumigatus conidia and hyphae.

Infection and immunity ·Vol. 57 ·No. 11 ·1989-11-00 ·Pages 3412-7

Kozel TR, Wilson MA, Farrell TP, Levitz SM

Abstract

Complement activation by Aspergillus fumigatus may play a crucial role in stimulating binding and killing of this organism by phagocytes. We examined the amount and type of C3 deposited on resting conidia, swollen conidia, and hyphae of A. fumigatus after incubation in pooled human serum. All three life forms of A. fumigatus were potent activators of the complement cascade, with deposition on the organisms of similar amounts of C3 per unit of surface area. The rate of deposition was slowest for resting conidia, although maximal deposition was still achieved within 40 min. The roles of the alternative and classical pathways were assessed by use of serum chelated with magnesium EGTA [magnesium ethylene glycol-bis(beta-aminoethyl ether)-N,N,N',N'-tetraacetic acid] and with an alternative pathway reconstituted from the six purified alternative-pathway proteins. Complement activation by resting conidia was mediated by the alternative pathway. In contrast, there was a progressive dependence on the classical pathway as the fungal particles matured into swollen conidia and then hyphae. Treatment with hydroxylamine, which disrupts ester linkages, removed 89 to 95% of the C3 bound to all three forms of A. fumigatus. This released C3 contained a mixture of C3b and iC3b, as determined by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and autoradiography. These data demonstrate that although all three forms of A. fumigatus are potent activators of the complement system, the transition from resting conidia to swollen conidia to hyphae results in progressive changes in the manner in which the fungal particles interact with the complement system. The lack of participation of the classical pathway in complement activation by resting conidia may have important implications regarding their ability to effectively stimulate phagocytes.

MeSH Terms
Aspergillus fumigatus/cytology,immunology Chelating Agents/pharmacology Complement Activation Complement C3/metabolism Complement C3b/metabolism Complement Pathway, Alternative Complement Pathway, Classical Humans In Vitro Techniques Kinetics Molecular Weight
Chemicals
Chelating Agents Complement C3 Complement C3b
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Kozel T R
Department of Microbiology, University of Nevada-Reno.
Wilson M A
Farrell T P
Levitz S M
References (38)
38 references, click to expand
  1. Interaction between the third complement protein and cell surface macromolecules.
    Proc Natl Acad Sci U S A. 1977 Jul;74(7):2701-5 PMID: 268620
  2. The alternative pathway C3/C5 convertase: chemical basis of factor B activation.
    J Immunol. 1979 Aug;123(2):529-34 PMID: 458145
  3. C3 shunt activation in human serum chelated with EGTA.
    J Immunol. 1972 Oct;109(4):807-9 PMID: 4627510
  4. C3 receptors on macrophages.
    J Cell Sci Suppl. 1988;9:67-97 PMID: 2978518
  5. Aspergillosis.
    Infect Dis Clin North Am. 1989 Mar;3(1):1-18 PMID: 2647828
  6. The binding of complement component C3 to antibody-antigen aggregates after activation of the alternative pathway in human serum.
    Biochem J. 1981 May 1;195(2):471-80 PMID: 7316962
  7. Activation of the alternative complement pathway: recognition of surface structures on activators by bound C3b.
    J Immunol. 1980 Feb;124(2):977-82 PMID: 7356723
  8. Inhibition of complement by culture supernatants of Aspergillus fumigatus.
    J Infect Dis. 1986 Dec;154(6):944-51 PMID: 3537152
  9. Activation of the complement system by Cryptococcus neoformans leads to binding of iC3b to the yeast.
    Infect Immun. 1986 Apr;52(1):1-5 PMID: 3514450
  10. The C3b inactivator of the human complement system: homology with serine proteases.
    FEBS Lett. 1981 Nov 16;134(2):147-50 PMID: 7030791
  11. Native and activated properdin: interconvertibility and identity of amino- and carboxy-terminal sequences.
    J Immunol. 1980 Feb;124(2):602-6 PMID: 6766162
  12. In vivo bronchoalveolar macrophage defense against Rhizopus oryzae and Aspergillus fumigatus.
    J Infect Dis. 1984 Nov;150(5):752-60 PMID: 6387001
  13. In vitro killing of spores and hyphae of Aspergillus fumigatus and Rhizopus oryzae by rabbit neutrophil cationic peptides and bronchoalveolar macrophages.
    J Infect Dis. 1986 Sep;154(3):483-9 PMID: 3525696
  14. Evidence for an ester linkage between the labile binding site of C3b and receptive surfaces.
    J Immunol. 1979 Sep;123(3):1388-94 PMID: 38283
  15. Purification and structural studies on the complement-system control protein beta 1H (Factor H).
    Biochem J. 1982 Aug 1;205(2):285-93 PMID: 6215918
  16. Membrane complement receptors specific for bound fragments of C3.
    Adv Immunol. 1985;37:217-67 PMID: 3159188
  17. Lectin-like attachment sites on murine pulmonary alveolar macrophages bind Aspergillus fumigatus conidia.
    J Infect Dis. 1988 Aug;158(2):407-14 PMID: 3042877
  18. A rapid colorimetric assay of fungal viability with the tetrazolium salt MTT.
    J Infect Dis. 1985 Nov;152(5):938-45 PMID: 2413145
  19. Fungal infection in chronic granulomatous disease. The importance of the phagocyte in defense against fungi.
    Am J Med. 1981 Jul;71(1):59-66 PMID: 7195647
  20. Mechanisms of resistance of Aspergillus fumigatus Conidia to killing by neutrophils in vitro.
    J Infect Dis. 1985 Jul;152(1):33-42 PMID: 2989387
  21. Damage to hyphal forms of fungi by human leukocytes in vitro. A possible host defense mechanism in aspergillosis and mucormycosis.
    Am J Pathol. 1978 May;91(2):313-28 PMID: 347942
  22. Molecular architecture of human properdin, a positive regulator of the alternative pathway of complement.
    J Biol Chem. 1984 Apr 10;259(7):4582-8 PMID: 6707020
  23. Activation of the alternate pathway of human complements by rabbit cells.
    J Immunol. 1974 Jul;113(1):348-58 PMID: 4134064
  24. Surface characteristics of Aspergillus conidia.
    Mycologia. 1969 May-Jun;61(3):560-71 PMID: 5812249
  25. Cleavage of C4b by C3b inactivator: production of a nicked form of C4b, C4b', as an intermediate cleavage product of C4b by C3b inactivator.
    J Immunol. 1980 Aug;125(2):578-82 PMID: 7391570
  26. Human factor B.
    Methods Enzymol. 1981;80 Pt C:102-12 PMID: 7043188
  27. Ligand-receptor interactions in the phagocytosis of virulent Streptococcus pneumoniae by polymorphonuclear leukocytes.
    J Infect Dis. 1986 Oct;154(4):619-26 PMID: 2943825
  28. Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphrenylglycoluril.
    Biochem Biophys Res Commun. 1978 Feb 28;80(4):849-57 PMID: 637870
  29. The physiological breakdown of the third component of human complement.
    Mol Immunol. 1980 Jan;17(1):9-20 PMID: 7360115
  30. Selective protection against conidia by mononuclear and against mycelia by polymorphonuclear phagocytes in resistance to Aspergillus. Observations on these two lines of defense in vivo and in vitro with human and mouse phagocytes.
    J Clin Invest. 1982 Mar;69(3):617-31 PMID: 7037853
  31. Interaction of Aspergillus fumigatus Spores with Human Leukocytes and Serum.
    Infect Immun. 1970 Apr;1(4):345-50 PMID: 16557740
  32. Activation and binding of opsonic fragments of C3 on encapsulated Cryptococcus neoformans by using an alternative complement pathway reconstituted from six isolated proteins.
    Infect Immun. 1989 Jul;57(7):1922-7 PMID: 2525113
  33. Inhibition of phagocytosis by cryptococcal polysaccharide: dissociation of the attachment and ingestion phases of phagocytosis.
    Infect Immun. 1976 Jul;14(1):62-7 PMID: 780279
  34. Damage to Aspergillus fumigatus and Rhizopus oryzae hyphae by oxidative and nonoxidative microbicidal products of human neutrophils in vitro.
    Infect Immun. 1982 Nov;38(2):487-95 PMID: 6292103
  35. Large scale isolation of functionally active components of the human complement system.
    J Biol Chem. 1981 Apr 25;256(8):3995-4006 PMID: 6783652
  36. Strain variation in phagocytosis of Cryptococcus neoformans: dissociation of susceptibility to phagocytosis from activation and binding of opsonic fragments of C3.
    Infect Immun. 1988 Nov;56(11):2794-800 PMID: 3049374
  37. Activation and binding of C3 by Candida albicans.
    Infect Immun. 1987 Aug;55(8):1890-4 PMID: 3301679
  38. Analysis of proteins and respiratory cells obtained from human lungs by bronchial lavage.
    J Lab Clin Med. 1974 Oct;84(4):559-73 PMID: 4412011
Article Info
Journal
Infection and immunity
Abbr.
Infect Immun
ISSN
0019-9567
Published
1989-11-00
Pages
3412-7
Language
English
Region
United States
NLM ID
0246127
PMCID
PMC259839
Subset
IM
Grants
NIAID NIH HHS · AI00658 · United States
NIAID NIH HHS · AI14209 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com